HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages.
Maria C VirgilioBarkha RamnaniThomas ChenW Miguel DisbennettJay LubowJoshua D WelchKathleen L CollinsPublished in: Nature communications (2024)
HIV-1 Vpr promotes efficient spread of HIV-1 from macrophages to T cells by transcriptionally downmodulating restriction factors that target HIV-1 Envelope protein (Env). Here we find that Vpr induces broad transcriptomic changes by targeting PU.1, a transcription factor necessary for expression of host innate immune response genes, including those that target Env. Consistent with this, we find silencing PU.1 in infected macrophages lacking Vpr rescues Env. Vpr downmodulates PU.1 through a proteasomal degradation pathway that depends on physical interactions with PU.1 and DCAF1, a component of the Cul4A E3 ubiquitin ligase. The capacity for Vpr to target PU.1 is highly conserved across primate lentiviruses. In addition to impacting infected cells, we find that Vpr suppresses expression of innate immune response genes in uninfected bystander cells, and that virion-associated Vpr can degrade PU.1. Together, we demonstrate Vpr counteracts PU.1 in macrophages to blunt antiviral immune responses and promote viral spread.
Keyphrases
- immune response
- hiv infected
- antiretroviral therapy
- hiv positive
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- transcription factor
- hiv aids
- induced apoptosis
- men who have sex with men
- poor prognosis
- toll like receptor
- dendritic cells
- endothelial cells
- genome wide
- cell cycle arrest
- south africa
- binding protein
- sars cov
- physical activity
- single cell
- gene expression
- long non coding rna
- mouse model
- small molecule
- amino acid
- genome wide identification
- pluripotent stem cells